Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17
GLP-1 agonists originally appeared as a treatment for people with type 2 diabetes
Multiple flavours and effervescent format
Symptoms frequently decrease over time as the body adapts and individuals change their eating habits and food choices
A combination of limited access and high popularity drives the expense
Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2)
The most robust data comes from Novo Nordisks large cardiovascular outcomes trial SELECT, which found semaglutide reduced CV event risk by 26% in high risk type 2 diabetics
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
